Visalytics
Visalytics
approved EB-2 (NIW)

Visiting Postdoctoral Fellow

Molecular Biology · 2025-07-28

Processing Time
54 days
Decision Date
2025-07-28
Location
Virginia
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to investigate the molecular mechanisms of cellular responses to DNA damage throughout the cell cycle using genetic engineering and advanced microscopy. This research aims to identify therapeutic targets that allow for the design of chemotherapeutic regimens that selectively target cancer cells while sparing healthy tissue. The ultimate goal is to mitigate the adverse side effects of chemotherapy and radiotherapy and improve long-term patient outcomes.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses urgent public-health needs by improving the safety and effectiveness of DNA damage-based cancer therapies.

2 Well-positioned to Advance the Endeavor Met

The petitioner's dual Ph.D. training and current appointment at a federal biomedical institute demonstrate the necessary expertise and resources.

3 On Balance, Beneficial to Waive Job Offer Met

The potential to decrease healthcare costs and improve patient outcomes through oncological innovation makes a waiver beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 5 peer-reviewed journal articles, a book chapter, and 274 citations, which demonstrated her influence in the field. Evidence included her dual Ph.D. training and her role at a leading federal biomedical institute, satisfying the well-positioned prong. The case successfully met all three Dhanasar prongs by linking her research to urgent U.S. public health needs and oncological innovation.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Others

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 464 days 2022-05-21
The petitioner proposes to continue the full characterization of cellular and genetic mechanisms related to cancers that interact with their surrounding microenvironment. The work focuses on improving treatment strategies, identifying therapeutic targets to slow metastasis, and mitigating the economic costs associated with cancer care.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-28.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 54 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist